Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review

Obstructive airway disease (OAD), which includes COPD and asthma, is the leading cause of morbidity and mortality in India. Long-acting bronchodilators (long-acting β2 agonists (LABAs) and/or long-acting muscarinic antagonists (LAMAs)) and inhaled corticosteroids (ICS) have a vital role in the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhar, Raja, Talwar, Deepak, Salvi, Sundeep, Muralimohan, B.V., Panchal, Sagar, Patil, Saiprasad, Bhagat, Sagar, Khatri, Nishtha, Barkate, Hanmant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958219/
https://www.ncbi.nlm.nih.gov/pubmed/35350278
http://dx.doi.org/10.1183/23120541.00556-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958219/
https://www.ncbi.nlm.nih.gov/pubmed/35350278
http://dx.doi.org/10.1183/23120541.00556-2021

Ejemplares similares